290 related articles for article (PubMed ID: 18785839)
1. Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins.
Deng Q; Barbieri JT
Annu Rev Microbiol; 2008; 62():271-88. PubMed ID: 18785839
[TBL] [Abstract][Full Text] [Related]
2. Stealth and mimicry by deadly bacterial toxins.
Yates SP; Jørgensen R; Andersen GR; Merrill AR
Trends Biochem Sci; 2006 Feb; 31(2):123-33. PubMed ID: 16406634
[TBL] [Abstract][Full Text] [Related]
3. Haploid genetic screens in human cells identify host factors used by pathogens.
Carette JE; Guimaraes CP; Varadarajan M; Park AS; Wuethrich I; Godarova A; Kotecki M; Cochran BH; Spooner E; Ploegh HL; Brummelkamp TR
Science; 2009 Nov; 326(5957):1231-5. PubMed ID: 19965467
[TBL] [Abstract][Full Text] [Related]
4. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry.
Jørgensen R; Merrill AR; Yates SP; Marquez VE; Schwan AL; Boesen T; Andersen GR
Nature; 2005 Aug; 436(7053):979-84. PubMed ID: 16107839
[TBL] [Abstract][Full Text] [Related]
5. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
Wilson BA; Collier RJ
Curr Top Microbiol Immunol; 1992; 175():27-41. PubMed ID: 1628498
[No Abstract] [Full Text] [Related]
6. ADP-ribosylating toxins.
Passador L; Iglewski W
Methods Enzymol; 1994; 235():617-31. PubMed ID: 8057931
[No Abstract] [Full Text] [Related]
7. The ubiquitin ligase Cbl-b limits Pseudomonas aeruginosa exotoxin T-mediated virulence.
Balachandran P; Dragone L; Garrity-Ryan L; Lemus A; Weiss A; Engel J
J Clin Invest; 2007 Feb; 117(2):419-27. PubMed ID: 17235393
[TBL] [Abstract][Full Text] [Related]
8. Novel bacterial ADP-ribosylating toxins: structure and function.
Simon NC; Aktories K; Barbieri JT
Nat Rev Microbiol; 2014 Sep; 12(9):599-611. PubMed ID: 25023120
[TBL] [Abstract][Full Text] [Related]
9. Structural complementation of the catalytic domain of pseudomonas exotoxin A.
Boland EL; Van Dyken CM; Duckett RM; McCluskey AJ; Poon GM
J Mol Biol; 2014 Feb; 426(3):645-55. PubMed ID: 24211469
[TBL] [Abstract][Full Text] [Related]
10. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
Parikh SL; Schramm VL
Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
[TBL] [Abstract][Full Text] [Related]
11. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins.
Domenighini M; Magagnoli C; Pizza M; Rappuoli R
Mol Microbiol; 1994 Oct; 14(1):41-50. PubMed ID: 7830559
[TBL] [Abstract][Full Text] [Related]
12. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens.
Kannan TR; Baseman JB
Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6724-9. PubMed ID: 16617115
[TBL] [Abstract][Full Text] [Related]
13. Insights into membrane protein folding and translocation from the behavior of bacterial toxins: models for membrane translocation.
London E; Ulbrandt ND; Tortorella D; Jiang JX; Abrams FS
Soc Gen Physiol Ser; 1993; 48():45-61. PubMed ID: 8503054
[No Abstract] [Full Text] [Related]
14. Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae.
Becker A; Kannan TR; Taylor AB; Pakhomova ON; Zhang Y; Somarajan SR; Galaleldeen A; Holloway SP; Baseman JB; Hart PJ
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5165-70. PubMed ID: 25848012
[TBL] [Abstract][Full Text] [Related]
15. Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A.
Yates SP; Merrill AR
Biochem J; 2004 May; 379(Pt 3):563-72. PubMed ID: 14733615
[TBL] [Abstract][Full Text] [Related]
16. The best defense is a good offense--Salmonella deploys an ADP-ribosylating toxin.
Lesnick ML; Guiney DG
Trends Microbiol; 2001 Jan; 9(1):2-4; discussion 4-5. PubMed ID: 11166220
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
Han S; Arvai AS; Clancy SB; Tainer JA
J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
[TBL] [Abstract][Full Text] [Related]
18. The nature and character of the transition state for the ADP-ribosyltransferase reaction.
Jørgensen R; Wang Y; Visschedyk D; Merrill AR
EMBO Rep; 2008 Aug; 9(8):802-9. PubMed ID: 18583986
[TBL] [Abstract][Full Text] [Related]
19. The biosynthesis and biological function of diphthamide.
Su X; Lin Z; Lin H
Crit Rev Biochem Mol Biol; 2013; 48(6):515-21. PubMed ID: 23971743
[TBL] [Abstract][Full Text] [Related]
20. Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha.
Morimoto H; Bonavida B
J Immunol; 1992 Sep; 149(6):2089-94. PubMed ID: 1517572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
